Chemistry Under the Hood Building a chemical characterization strategy for smart cardiac implants that holds up to FDA scrutiny
Sponsored by: Jordi Labs and RQM+
Smart cardiac implants face heightened FDA scrutiny due to their chemical complexity. This white paper explains how early, advanced testing can reduce delays, costs, and regulatory risk while supporting smoother PMA review. Download the white paper to learn more.
Download this ebook to explore how biomarkers enable precision medicine across drug discovery and clinical development. Learn key strategies, real-world case studies, and emerging technologies that improve trial success and patient stratification.
